Stem cells are likely to be used as an alternate source of biological material for neural transplantation to treat Parkinson’s disease in the not too distant future. Among the several ethical criteria that must be fulfilled before proceeding with clinical research, a favourable benefit to risk ratio must be obtained. The potential benefits to the participant and to society are evaluated relative to the risks in an attempt to offer the participants a reasonable choice. Through examination of preclinical studies transplanting stem cells in animals and the transplantation of fetal tissue in patients with Parkinson’s disease, a current set of potential benefits and risks for neural transplantation of stem cells in clinical research of Parkinson’s disease are derived. The potential benefits to research participants undergoing stem cell transplantation are relief of parkinsonian symptoms and decreasing doses of parkinsonian drugs. Transplantation of stem cells as a treatment for Parkinson’s disease may benefit society by providing knowledge that can be used to help determine better treatments in the future. The risks to research participants undergoing stem cell transplantation include tumour formation, inappropriate stem cell migration, immune rejection of transplanted stem cells, haemorrhage during neurosurgery and postoperative infection. Although some of these risks are general to neurosurgical transplantation and may not be reduced for participants, the potential risk of tumour formation and inappropriate stem cell migration must be minimised before obtaining a favourable potential benefit to risk calculus and to provide participants with a reasonable choice before they enrol in clinical studies.
- DBS, deep brain stimulation
- FVM, fetal ventral mesencephalic
- IRB, institutional review board
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests: None.
Read the full text or download the PDF:
Other content recommended for you
- Stem cell transplantation in neurodegenerative disorders of the gastrointestinal tract: future or fiction?
- The therapeutic potential of stem cells from adults
- Current Science of Regenerative Medicine with Stem Cells
- Why the apparent haste to clone humans?
- Stem cells as a resource for regenerative neurology
- Stem cell stories: from bedside to bench
- Stem cells in myocardial infarction: from bench to bedside
- Cellular and molecular imaging for stem cell tracking in neurological diseases
- The new stem cell biology: something for everyone
- Ethical and legal aspects of stem cell practices in Turkey: where are we?